RCE 2.86% 51.0¢ recce pharmaceuticals ltd

Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study, page-14

  1. 5,354 Posts.
    lightbulb Created with Sketch. 689
    We are still waiting for human efficacy data on something or anything frustratingly at this stage. Phase 1 looks good so far in multiple patients but to date it seems we still havent cured any infection in a human as part of any documented trial.
    Im so hoping to see that day as back of my mind says too good to be true but initial burns data looked awesome. Still cant believe that has gone silent and no one is challenging this in any interviews. There can surely be no question now that they know how it went and they chose not to reveal results??
    Last edited by andrewk65: 12/07/23
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
51.0¢
Change
-0.015(2.86%)
Mkt cap ! $118.1M
Open High Low Value Volume
52.0¢ 52.0¢ 50.5¢ $40.89K 79.63K

Buyers (Bids)

No. Vol. Price($)
1 677 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
52.5¢ 392 1
View Market Depth
Last trade - 15.59pm 13/09/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.